Supreme Court Keeps Mifepristone Available by Mail as the FDA Declines to Defend Its Own Rule

Date

May 14, 2026

Outcome

Pending

Posture

Interim

Party

United States

Source

scotusblog.com ↗

Publisher

SCOTUSblog

Disposition

The Supreme Court extended a stay of the Fifth Circuit ruling, preserving mail and telehealth access to mifepristone while the litigation proceeds; Thomas and Alito dissented.

Ledger id

1455

Full record

Read the full 47watch record →